Send the following on WhatsApp
Continue to ChatKRAS 突變 NSCLC 二線治療有解?Sotorasib 二期臨床顯 PFS 效益 https://geneonline.news/sotorasib-kras-g12c-inhibitor/?variant=zh-cn
KRAS 突變 NSCLC 二線治療有解?Sotorasib 二期臨床顯 PFS 效益 https://geneonline.news/sotorasib-kras-g12c-inhibitor/?variant=zh-cn